Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio‐Oncology Society

Lyon, Alexander R. ; Dent, Susan ; Stanway, Susannah ; Earl, Helena ; Brezden‐Masley, Christine ; Cohen‐Solal, Alain ; Tocchetti, Carlo G. ; Moslehi, Javid J. ; Groarke, John D. ; Bergler‐Klein, Jutta ; Khoo, Vincent ; Tan, Li Ling ; Anker, Markus S. ; Haehling, Stephan ; Maack, Christoph ; Pudil, Radek ; Barac, Ana ; Thavendiranathan, Paaladinesh ; Ky, Bonnie ; Neilan, Tomas G. ; Belenkov, Yury ; Rosen, Stuart D. ; Iakobishvili, Zaza ; Sverdlov, Aaron L. ; Hajjar, Ludhmila A. ; Macedo, Ariane V.S. ; Manisty, Charlotte ; Ciardiello, Fortunato ; Farmakis, Dimitrios ; Boer, Rudolf A. ; Skouri, Hadi ; Suter, Thomas M. ; Cardinale, Daniela ; Witteles, Ronald M. ; Fradley, Michael G. ; Herrmann, Joerg ; Cornell, Robert F. ; Wechelaker, Ashutosh ; Mauro, Michael J. ; Milojkovic, Dragana ; Lavallade, Hugues ; Ruschitzka, Frank ; Coats, Andrew J.S. ; Seferovic, Petar M. ; Chioncel, Ovidiu ; Thum, Thomas ; Bauersachs, Johann ; Andres, M. Sol ; Wright, David J. ; López‐Fernández, Teresa ; Plummer, Chris ; Lenihan, Daniel

European journal of heart failure, 2020-11, Vol.22 (11), p.1945-1960 [Periódico revisado por pares]

Oxford, UK: John Wiley & Sons, Ltd

Texto completo disponível